Newsroom
23 press releases and 54 media coverage stories
ScaleReady Joins the Alliance for Regenerative Medicine
alliancerm.org
As a member of The Alliance for Regenerative Medicine (ARM), ScaleReady committed to progressing regenerative medicine and advanced therapy manufacturing using its innovative and high throughput manufacturing platform.
Read the article : ScaleReady Joins the Alliance for Regenerative MedicineShare: ScaleReady Joins the Alliance for Regenerative Medicine
ScaleReady hosts ISCT Symposium on Intelligent Scale-up
youtube.com
ScaleReady recruited a prestigious panel of cell therapy manufacturing experts to discuss their experiences and strategies for commercial scale up and scale out. The panel featured: Juan Vera, MD James…
Read the release : ScaleReady hosts ISCT Symposium on Intelligent Scale-upShare: ScaleReady hosts ISCT Symposium on Intelligent Scale-up
RegMedNet interviews Josh Ludwig, Global Commercial Director
RegMedNet
In this interview, Josh Ludwig, Global Director of Commercial Operations at ScaleReady, describes how a scalable, cost-effective and practical manufacturing platform for cell and gene therapies (CGTs) can be achieved.
Read the article : RegMedNet interviews Josh Ludwig, Global Commercial DirectorShare: RegMedNet interviews Josh Ludwig, Global Commercial Director
ScaleReady Launches
Business Wire
ScaleReady launches with the mission to make cell and gene therapy manufacturing practical and viable. Through a partnership between Bio-Techne, Fresenius Kabi, and Wilson Wolf, ScaleReady is able to provide…
Read the release : ScaleReady LaunchesShare: ScaleReady Launches
Joint Venture formed by Bio-Techne, Fresenius Kabi, and Wilson Wolf
Bio-Techne
The joint venture focuses on providing scalable manufacturing technologies needed to develop and commercialize new cell and gene therapies. Each partner contributes industry-leading products and unique expertise to the new…
Read the release : Joint Venture formed by Bio-Techne, Fresenius Kabi, and Wilson WolfShare: Joint Venture formed by Bio-Techne, Fresenius Kabi, and Wilson Wolf
